The Angelman Syndrome Clinic at Riley Children’s Hospital, associated with the Indiana University School of Medicine Department of Psychiatry, is conducting a new research study in individuals ages 3 years and older with Angelman syndrome. This study hopes to move the field of Angelman research forward by developing a greater understanding of specific behavioral symptoms commonly associated with Angelman syndrome, as well as identifying substances in the blood which may be associated with the neurobiology of Angelman syndrome.
This study involves cognitive, behavioral, and quality of life assessments including parent/caregiver checklists and interviews, and cognitive testing, autism screening, and eye gaze assessment of the individual with Angelman syndrome. Study participants may also participate in an optional one-time blood draw.
This study can be completed in approximately eight hours, and can be done in a single visit or multiple visits to our clinic based on needs of the individual and their caregiver. Each study participant/caregiver will receive $100 to help defray travel costs. Participants will also receive an extensive psychiatric/medical/neurological evaluation which is provided free-of-charge and a report detailing the findings of the cognitive, behavioral, and eye gaze testing. All subjects will be notified upon completion of the study and will be offered a copy of all publications that result from this project. Taking part in the study is voluntary and you will not be contacted unless you contact us to arrange to participate.
If you would like to participate or have further questions, please email:
Logan Wink, M.D.
Department of Psychiatry
Indiana University School of Medicine
705 Riley Hospital Drive, Rm. 4300
Indianapolis, Indiana 46202-4800
The Angelman Syndrome Foundation does not endorse any clinical trial or study, but provides information to the AS community for its own consideration.